These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20885358)

  • 1. Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance.
    Li WQ; Li YM; Tao BB; Lu YC; Hu GH; Liu HM; He J; Xu Y; Yu HY
    Med Sci Monit; 2010 Oct; 16(10):HY27-30. PubMed ID: 20885358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCG2: the key to chemoresistance in cancer stem cells?
    An Y; Ongkeko WM
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1529-42. PubMed ID: 19708828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells.
    Martín V; Sanchez-Sanchez AM; Herrera F; Gomez-Manzano C; Fueyo J; Alvarez-Vega MA; Antolín I; Rodriguez C
    Br J Cancer; 2013 May; 108(10):2005-12. PubMed ID: 23632480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
    Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
    Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
    Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M
    Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric glioblastoma cell line shows different patterns of expression of transmembrane ABC transporters after in vitro exposure to vinblastine.
    Valera ET; de Freitas Cortez MA; de Paula Queiroz RG; de Oliveira FM; Brassesco MS; Jabado N; Faury D; Bobola MS; Machado HR; Scrideli CA; Tone LG
    Childs Nerv Syst; 2009 Jan; 25(1):39-45. PubMed ID: 18946672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA profiling in K-562 cells under imatinib treatment: influence of miR-212 and miR-328 on ABCG2 expression.
    Turrini E; Haenisch S; Laechelt S; Diewock T; Bruhn O; Cascorbi I
    Pharmacogenet Genomics; 2012 Mar; 22(3):198-205. PubMed ID: 22241070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme.
    Li Y; Li W; Yang Y; Lu Y; He C; Hu G; Liu H; Chen J; He J; Yu H
    Brain Res; 2009 Aug; 1286():13-8. PubMed ID: 19559015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
    To KK; Leung WW; Ng SS
    Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
    Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
    Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
    Cheng W; Liu T; Wan X; Gao Y; Wang H
    FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The homeobox gene MSX2 determines chemosensitivity of pancreatic cancer cells via the regulation of transporter gene ABCG2.
    Hamada S; Satoh K; Hirota M; Kanno A; Umino J; Ito H; Masamune A; Kikuta K; Kume K; Shimosegawa T
    J Cell Physiol; 2012 Feb; 227(2):729-38. PubMed ID: 21465479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCG2: determining its relevance in clinical drug resistance.
    Robey RW; Polgar O; Deeken J; To KW; Bates SE
    Cancer Metastasis Rev; 2007 Mar; 26(1):39-57. PubMed ID: 17323127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
    Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
    Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics.
    Boesch M; Zeimet AG; Rumpold H; Gastl G; Sopper S; Wolf D
    Stem Cells Transl Med; 2015 Sep; 4(9):1028-32. PubMed ID: 26136502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs.
    Sukowati CH; Anfuso B; Pascut D; Tiribelli C
    Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):723-5. PubMed ID: 25920931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated miR-132 in Lgr5
    Zhang L; Guo X; Zhang D; Fan Y; Qin L; Dong S; Zhang L
    Mol Carcinog; 2017 Sep; 56(9):2022-2034. PubMed ID: 28383763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
    Liu T; Xu F; Du X; Lai D; Liu T; Zhao Y; Huang Q; Jiang L; Huang W; Cheng W; Liu Z
    Mol Cell Biochem; 2010 Jul; 340(1-2):265-73. PubMed ID: 20224986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.
    Patrawala L; Calhoun T; Schneider-Broussard R; Zhou J; Claypool K; Tang DG
    Cancer Res; 2005 Jul; 65(14):6207-19. PubMed ID: 16024622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
    Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M
    Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.